Computational Target Analysis for Chronic Myelogenous Leukemia Therapy

Supplementary Material 2 from a study on multimodal gene and targeted drug therapy for chronic myelogenous leukemia. The 11.8 KB XLSX file contains supporting data for computational target analysis and therapeutic validation. Author Margaret L. Lugin published the file on figshare in April 2026.

Use Cases

• Analyze gene expression or drug target data referenced in the main study's computational analysis.
• Validate therapeutic targets for BIM/MCL-1 chimeric nanoparticles against chronic myelogenous leukemia.
• Cross-reference supplementary tables or figures on drug-gene interactions from the associated research paper.

Strengths

• Data is directly linked to a peer-reviewed research study on a specific cancer therapy.
• File is openly available under a permissive CC-BY-4.0 license.
• Published in April 2026, indicating recent research activity.

Limitations

• The dataset is very small at 11.8 KB, suggesting limited scope as supplementary material.
• Specific column names, row counts, and data structure are not described.
• Content is entirely dependent on the context of the parent research paper.

Provenance

Source

figshare, authored by Margaret L. Lugin.

Collection Method

Generated as supplementary material for a computational and experimental research study.

Freshness

Last updated April 2026.